Tech Company M&A Transactions
Omniome Acquisition
Based in San Diego, Omniome was acquired by Pacific BioSciences of California. Deal value was $800 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/20/2021
Transaction Type
M&A
Amount
$800,000,000
M&A Terms
The deal includes upfront consideration of approximately $600 million consisting of 9.4 million shares of PacBio common stock and $300 million in cash, plus an additional $200 million in cash and stock payable with the first commercial shipment of an SBB sequencer. The overall transaction is valued at approximately $800 million.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
6965 Lusk Blvd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
At Omniome, we are developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy. The accuracy of our novel sequencing approach has the potential to advance cancer diagnostics, drive higher fidelity for single-cell applications, and broadly enable clinical sequencing--even in regions of the genome prone to sequencing errors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ken Song
Chief Executive Officer
David Mullarkey
Chief Technical Officer
Arnold Oliphant
VP - Bus. Development
Marc Montserrat
VP - Finance
Kelly Perez
Browse more venture capital transactions:
Prev: 7/20/2021: Julia Computing venture capital transaction
Next: 7/20/2021: Quit Genius venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs